{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-23-001479","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.588032+00:00","generated_at":"2026-06-12T02:06:19.963998+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Artelo Biosciences increases CEO base salary to $500,000","bullets":["CEO Gregory D. Gorgas annual base salary raised from $475,000 to $500,000 effective August 4, 2023.","Target bonus remains unchanged at 50% of base salary subject to performance objectives.","Compensation Committee approved the increase; no other officer compensation changes disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-23-001479","json":"https://secwatch.observer/filing/0001640334-23-001479.json","markdown":"https://secwatch.observer/filing/0001640334-23-001479.md","text":"https://secwatch.observer/filing/0001640334-23-001479.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033423001479/0001640334-23-001479-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033423001479/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T02:06:19.963998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}